60 DEGREES PHARMACEUTICALS, INC. as the Company and as Trustee Subordinated Indenture Dated as of , 20Subordinated Indenture • July 12th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
SUBORDINATED INDENTURE, dated as of , 20 , between 60 Degrees Pharmaceuticals, Inc., a Delaware corporation, as the Company, and , as Trustee.
At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • July 12th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
CLINICAL TRIAL AGREEMENT PROTOCOL NUMBER: TQ-BA-2024-1 (NCT06207370) PROTOCOL TITLE: “Double-blind Placebo-controlled Study to Assess the Safety and Efficacy of Oral Tafenoquine plus Standard of Care versus Placebo plus Standard of Care in Patients...Clinical Trial Agreement • July 12th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
This Clinical Trial Agreement (this “Agreement”) is effective as of the last date of signature (the “Effective Date”) and sets forth certain agreements by and between 60 DEGREES PHARMACEUTICALS, INC , having its principal place of business at 1025 Connecticut Ave NW, Washington DC, 20036 (“Sponsor”), and TUFTS MEDICINE, INC., a Massachusetts not-for-profit corporation, on behalf of its affiliates, including but not limited to, Tufts Medical Center, Inc., Lowell General Hospital, MelroseWakefield Healthcare, and Home Health Foundation, with a principal place of business at 800 Washington Street, Boston, MA 02111INSTITUTION ADDRESS (hereinafter referred to as “Institution”). The persons executing this Agreement hereby represent that they are authorized to do so for and on behalf of the above-named companies and organizations.
VETERINARY TRIAL AGREEMENT Sponsor Agreement Number (if any): Not applicable NC State RED Number: PAM-P24-003176Veterinary Trial Agreement • July 12th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
This Veterinary Trial Agreement (“Agreement”) is entered into by and between North Carolina State University, Raleigh North Carolina (hereinafter called “University”), and 60 Degrees Pharmaceuticals LLC with a principal place of business at 1025 Connecticut Avenue NW Suite 1000, Washington DC, 20036 (hereinafter called “Sponsor”) (Individually referred to as “Party” and collectively hereinafter referred to as “Parties”).
SPONSORED PROJECT AGREEMENT Sponsor Agreement Number (if any): N/A NC State RED Number: PAM-P24-003709Sponsored Project Agreement • July 12th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
This Sponsored Project Agreement is entered into by and between North Carolina State University, Raleigh North Carolina (hereinafter called “University”), and 60 Degrees Pharmaceuticals INC with a principal place of business at 1025 Connecticut Avenue NW Suite 1000, Washington DC, 20036 (hereinafter called “Sponsor”) (Individually referred to as a “Party” and collectively hereinafter called “Parties”).
